Articles From: Insight Launches Online Resource for Healthcare Community to InspireMD Appoints Dr. James Barry as Chief Operating Officer


TEMPE, Ariz., July 30, 2014 (GLOBE NEWSWIRE) -- Insight (Nasdaq:NSIT) , a leading worldwide technology provider of hardware, software and service solutions in healthcare environments across the U.S., today announced the launch of Insight ON: Healthcare , a news and digital information resource created to help the healthcare community navigate myriad IT challenges.
Sign-up for Insight Launches Online Resource for Healthcare Community investment picks
TEMPE, Ariz., Aug.
Sign-up for Insight Named Microsoft Federal Partner of the Year investment picks
TEMPE, Ariz., Aug.
Sign-up for Insight Publishes Back to School Guidelines as Classrooms Brace for Tech Influx investment picks
TEMPE, Ariz., July 15, 2014 (GLOBE NEWSWIRE) -- Insight Enterprises , Inc. (Nasdaq:NSIT) , a leading worldwide technology provider of hardware, software and service solutions, was recognized today as a finalist for the 2014 Microsoft Volume Licensing Partner of the Year Award .
Sign-up for Insight Recognized as Finalist for Microsoft Volume Licensing Partner of the Year Award investment picks
TEMPE, Ariz., July 28, 2014 (GLOBE NEWSWIRE) -- Insight Enterprises , Inc. (Nasdaq:NSIT) , a leading worldwide technology provider of hardware, software and service solutions, has been named a 2014 Microsoft Cloud Licensing Solutions Provider (LSP) Sales Achievement Winner.
Sign-up for Insight Recognized as Microsoft Cloud Sales Achievement Award Winner investment picks
New online public charter school offers individualized learning approach for Michigan students LANSING, Mich.
Sign-up for Insight School of Michigan Opens Its Doors for the First Time to Students Enrolled for 2014-15 School Year investment picks
Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today announced that it was added to the Russell Microcap® Index.
Sign-up for Insignia Systems, Inc. Added to Russell Microcap® Index investment picks
Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today reported financial results for the three (“Q2”) and six months ended June 30, 2014, as compared to Q2 and six months ended June 30, 2013.
Sign-up for Insignia Systems, Inc. Announces 2014 Second Quarter and Six Months Financial Results investment picks
Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today announced that it has secured continued access in all retailers that it had previously served under the Company’s Retail Access and Distribution Agreement with Valassis In-Store Solutions (“Valassis”). As previously announced, the agreement between Insignia and Valassis terminated effective August 11, 2014.
Sign-up for Insignia Systems, Inc. Retains Access in All Retailers Previously Available under Its Agreement with Valassis investment picks
Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today announced that its President & CEO, Glen Dall will present at the Craig-Hallum Capital Group Alpha Select Conference on Thursday, September 18 th at 4:10 pm ET, at the Convene Conference Center in New York City.
Sign-up for Insignia Systems, Inc. to Present at the Craig-Hallum Capital Group Alpha Select Conference on Thursday, September 18th investment picks
Insignia Systems, Inc. (Nasdaq:ISIG) (“Insignia” or “the Company”) today announced that it will issue its financial results for the second quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the close of the stock market.
Sign-up for Insignia Systems, Inc. to Report 2014 Second Quarter Financial Results and Conduct Conference Call on Wednesday, July 30, 2014 investment picks
InSite Vision Incorporated (OTCBB:INSV) today announced that the United States Patent and Trademark Office (USPTO) has issued a U.S. Patent No.
Sign-up for InSite Vision Announces the Issuance of Broad U.S. Patent Covering Bromfenac Formulations in DuraSite® investment picks
Following a June 16, 2014 meeting with the U.S. Food and Drug Administration (FDA), InSite Vision Incorporated (OTCBB:INSV) today announced that it intends to submit a New Drug Application (NDA) for DexaSite ™ (dexamethasone 0.1% in DuraSite) as a treatment for blepharitis in adults during 2015, following completion of remaining chemistry and manufacturing work.
Sign-up for InSite Vision Plans to Submit New Drug Application to FDA for DexaSite™ for the Treatment of Blepharitis in Adults investment picks
InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended June 30, 2014.
Sign-up for InSite Vision Reports Second Quarter 2014 Financial Results investment picks
InSite Vision Incorporated (OTCBB:INSV) announced that it will report financial results for the quarter ended June 30, 2014 on Wednesday, August 13, 2014.
Sign-up for InSite Vision to Report Second Quarter 2014 Financial Results on August 13, 2014 investment picks
InSite Vision Incorporated (OTCBB: INSV) will hold its Annual Meeting of Stockholders at 10:00 a.m. Pacific Time on Wednesday, July 16, 2014 at the company's headquarters at 965 Atlantic Avenue, Alameda, California.
Sign-up for InSite Vision to Webcast Annual Meeting of Stockholders on July 16, 2014 investment picks
Insmed Incorporated (Nasdaq:INSM) announced the closing of a $115.1 million underwritten public offering of 10,235,000 shares of common stock, including 1,335,000 shares of common stock which were issued pursuant to the exercise of the underwriters' option to purchase additional shares, at a price of $11.25 per share to the public.
Sign-up for Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares investment picks
Insmed Incorporated (Nasdaq: INSM) announced today that it priced an offering of 8.9 million shares of its common stock at a price of $11.25 per share in a registered underwritten public offering for gross proceeds totaling approximately $100 million.
Sign-up for Insmed Announces Pricing of Public Offering of Common Stock investment picks
Insmed Incorporated (Nasdaq:INSM) announced today that it has commenced an underwritten public offering of $80 million of its common stock.
Sign-up for Insmed Announces Proposed Public Offering of Common Stock investment picks
Insmed Incorporated (Nasdaq: INSM) today announced that, following discussions with European regulatory authorities, it intends to file by the end of 2014 a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for ARIKAYCE™, or liposomal amikacin for inhalation, for the treatment of nontuberculous mycobacteria (NTM) lung infections in treatment refractory patients as well as for Pseudomonas aeruginosa lung infections in cystic fibrosis (CF) patients.
Sign-up for Insmed Provides Regulatory Update for ARIKAYCE investment picks
Insmed Incorporated (Nasdaq:INSM) today reported financial results for the three and six months ended June 30, 2014.
Sign-up for Insmed Reports Second Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201303/58593_insmed.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142396&ProfileId=051205&sourceType=1 BRIDGEWATER, NJ --
Sign-up for Insmed to Present at the Rodman & Renshaw Annual Global Investment Conference investment picks
Insperity, Inc. (NYSE:NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today announced that it has extended its arrangement for medical and dental coverage through 2017 with UnitedHealthcare , a UnitedHealth Group company (NYSE:UNH). This arrangement reflects a further strengthening of Insperity’s business relationship with UnitedHealthcare, as well as a commitment by the company to help small and medium-sized businesses navigate the effects of health care reform.
Sign-up for Insperity and UnitedHealthcare Extend Contract Through 2017 investment picks
Insperity, Inc. (NYSE:NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the second quarter and six months ended June 30, 2014.
Sign-up for Insperity Announces Second Quarter Results investment picks
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today announced that its board of directors has declared a quarterly cash dividend of $0.19 per share.
Sign-up for Insperity Declares Quarterly Dividend of $0.19 investment picks
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, will release its second quarter earnings prior to the open of the New York Stock Exchange on Friday, August 1, 2014.
Sign-up for Insperity Second Quarter Earnings Conference Call Friday, August 1 investment picks
2014/9/5
Aramark's Leadership Series Explores Higher Education's Opportunities to Adapt and Evolve PHILADELPHIA , Sept.
Sign-up for Inspirational Innovation in Higher Education investment picks
The South Island’s towering mountains and plunging rivers mix with the North Island’s sun-soaked coastal plains to bring Whole Foods Market (NASDAQ: WFM) shoppers six amazing wines from New Zealand, a wine region that continues to surprise and delight wine lovers.
Sign-up for Inspired by Europe and Re-Imagined with a Clean, Green Island Spirit, Six New Zealand Wines Will Be Featured This Fall at Whole Foods Market® investment picks
2014/7/8
100% procedural success rate achieved in first multi-specialty clinical experience BOSTON , July 8, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it has concluded enrollment in its CARENET clinical trial.
Sign-up for InspireMD Announces Successful Completion of CGuard™ CARENET (CARotid Embolic protection study using microNET) Trial investment picks
2014/7/15
Strengthens Leadership Team with Addition of Experienced Medical Device Executive BOSTON , July 15, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced the appointment of James Barry , Ph.D. as Chief Operating Officer.
Sign-up for InspireMD Appoints Dr. James Barry as Chief Operating Officer investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Insight Launches Online Resource for Healthcare Community to InspireMD Appoints Dr. James Barry as Chief Operating Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices